lifestyle.celebhomes.net
Home
Sample Page
Author:
Septerna, Inc.
Septerna Highlights Business Progress and Reports First Quarter 2026 Financial Results
May 11, 2026
Septerna to Present at Bank of America Securities Health Care Conference
May 5, 2026
Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism
April 13, 2026
Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
March 9, 2026